Login

Hossein Ehsanbakhsh

ORCID: 0000-0001-7684-8487
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5008600671
Research Areas
  • Animal Virus Infections Studies
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Insect and Pesticide Research
  • Autism Spectrum Disorder Research
  • Curcumin's Biomedical Applications
  • Nanoplatforms for cancer theranostics
  • Nuclear Receptors and Signaling
  • Insect symbiosis and bacterial influences
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological diseases and metabolism
  • Nanoparticle-Based Drug Delivery

Islamic Azad University, Science and Research Branch
 2018-2019

Shahid Beheshti University of Medical Sciences
 2017

 A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations
OPENALEX - Publications 
Shaghayegh Taghavi Rita Chaouni Abbas Tafakhori Luís Azcona Saghar Ghasemi Firouzabadi and 43 more Mir Davood Omrani Javad Jamshidi Babak Emamalizadeh Gholam Ali Shahidi Mona Ahmadi Seyed Amir Hassan Habibi Azadeh Ahmadifard Atena Fazeli Marzieh Motallebi Peyman Petramfar Saeed Askarpour Shiva Askarpour Hossein Ali Shahmohammadibeni Neda Shahmohammadibeni Hajar Eftekhari Amir Ehtesham Shafiei Zarneh Saeed Mohammadihosseinabad Mehdi Khorrami Safa Najmi Ahmad Chitsaz Parasto Shokraeian Hossein Ehsanbakhsh Jalal Rezaeidian Reza Ebrahimi Rad Faranak Madadi Monavvar Andarva Elham Alehabib Minoo Atakhorrami Seyed Erfan Mortazavi Zahra Azimzadeh Mahdis Bayat Amir Mohammad Besharati Mohammad Ali Harati-Ghavi Samareh Omidvari Zahra Dehghani-Tafti Faraz Mohammadi Banafsheh Mohammad Hossein Pour Hamid Noorollahi Moghaddam Ehsan Esmaili Shandiz Arman Habibi Zahra Taherian‐Esfahani Hossein Darvish Coro Paisán‐Ruiz

10.1007/s12035-017-0535-1 article EN Molecular Neurobiology 2017-05-13
 SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates
OPENALEX - Publications 
Reza Alimohammadi Meysam Porgoo Mohamad Eftekhary Seyed Hossein Kiaie Ehsan Ansari Dezfouli and 45 more Maryam Dehghani Kaveh Nasrollahi Talieh Malekshahabi Maryam Heidari Sedigheh Pouya Masoumeh Alimohammadi Dorsa Sattari Khavas Mohammad Sadra Modaresi Mohammad Hossein Ghasemi Hamed Ramyar Fatemeh Mohammadipour Fateme Hamzelouei Ahmadreza Mofayezi Seyed Saeed Mottaghi Amirhosein Rahmati Mohsen Razzaznian Vista Tirandazi Mahdi Tat Fatemeh Borzouee Hossein Sadeghi Melika Haji Mohammadi Leila Rastegar Seyed Milad Safar Sajadi Hossein Ehsanbakhsh Hamed Bazmbar Zeinab Baghernejadan Maedeh Shams Nouraei Pouya Pazooki Mina Pahlavanneshan Khadijeh Alishah Fateme Nasiri Neda Mokhberian Seyedeh Shima Mohammadi Shima Akar Hamidreza Niknam Marzieh Azizi Mohammad Ajoudanian Mohammad Hossein Moteallehi-Ardakani Seyed Ali Mousavi Shaegh Reihaneh Ramezani Vahid Salimi R. Moazzami Seyed Mahmoud Hashemi Somaye Dehghanizadeh Vahid Khoddami

At the forefront of biopharmaceutical industry, messenger RNA (mRNA) technology offers a flexible and scalable platform to address urgent need for world-wide immunization in pandemic situations. This strategic powerful has recently been used immunize millions people proving both safety highest level clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report COReNAPCIN®; vaccine candidate SARS-CoV-2 infection....

10.1038/s41541-022-00528-3 article EN cc-by npj Vaccines 2022-09-02
 Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line
OPENALEX - Publications 
Mohsen Chiani Attabak Toofani Milani Mahdieh Nemati Jalal Rezaeidian Hossein Ehsanbakhsh and 4 more Zohre Ahmadi Ebrahim Mazloomi Vahideh Sadeghi Azim Akbarzadeh

Background: Drug delivery systems have been designed to achieve targeted and control the release rate of drugs. A serious challenge associated with drug is presence blood-brain barrier which limits drugs penetration. In current study, effects cisplatin nanoparticles on A172 brain cancer cell line were investigated. Methods: Cisplatin produced by miniemulsion polymerization technique their properties evaluated. assay was performed characterize nanoparticles’ properties. Here, we examined free...

10.31557/apjcp.2019.20.1.303 article EN cc-by Asian Pacific Journal of Cancer Prevention 2019-01-01
 mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates
OPENALEX - Publications 
Reza Alimohammadi Meysam Porgoo Mohamad Eftekhary Seyed Hossein Kiaie Ehsan Ansari Dezfouli and 43 more Maryam Dehghani Kaveh Nasrollahi Talieh Malekshahabi Maryam Heidari Sedigheh Pouya Masoumeh Alimohammadi Dorsa Sattari Khavas Mohammad Sadra Modaresi Mohammad Hossein Ghasemi Hamed Ramyar Fatemeh Mohammadipour Fateme Hamzelouei Ahmadreza Mofayezi Seyed Saeed Mottaghi Amirhosein Rahmati Mohsen Razzaznian Vista Tirandazi Fatemeh Borzouee Hossein Sadeghi Melika Haji Mohammadi Leila Rastegar Seyed Milad Safar Sajadi Hossein Ehsanbakhsh Hamed Bazmbar Maedeh Shams Nouraee Pouya Pazooki Mina PahlevanNeshan Khadijeh Alishah Fateme Nasiri Neda Mokhberian Seyedeh Shima Mohammadi Shima Akar Hamidreza Niknam Marzyieh Azizi Mohammad Ajoudanian Mohammad Hossein Moteallehi-Ardakani Seyed Ali Mousavi Shaegh Reihaneh Ramezani Vahid Salimi R. Moazzami Seyed Mahmoud Hashemi Somaye Dehghanizadeh Vahid Khoddami

At the forefront of biopharmaceutical industry, messenger RNA (mRNA) technology offers a flexible and scalable platform to address urgent need for world-wide immunization in pandemic situations. This strategic powerful has recently been used immunize millions people proving both safety highest level clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report COReNAPCIN ® ; vaccine candidate SARS-CoV-2 infection. is...

10.1101/2022.03.05.483092 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-03-07
Coming Soon ...